Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

May 22, 2012

Urorec

Bookmark and Share

Company: Recordati Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Silodosin 4mg, 8mg. Description: Resp. yellow or white, opaque, hard gelatin capsules. Presentation: 4mg-30, €19.80; 8mg-30, €19.80. Indication: Treatment of the symptoms of benign prostatic hyperplasia (BPH). Pharmacology: Silodosin is highly selective for α1A‑adrenoreceptors that are primarily located in the human prostate, bladder [...]

Zolpidem Tartrate Teva

Bookmark and Share

Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Zolpidem (tartrate) 5mg, 10mg. Description: White, oval, biconvex, film-coated tablets marked ZIM on one side and 5 on reverse or ZIM10 on one side, resp. Presentation: 5mg-28, €1.32; 10mg-28, €2.64. Indication: Short term treatment of insomnia. Pharmacology: Zolpidem is a non-benzodiazepine hypnotic agent [...]

Actavis Gemcitabine 2g

Bookmark and Share

Company: Actavis Ireland Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Gemcitabine (as HCl) 2g. Description: Powder for solution for infusion. Presentation: Vial. Price available on request. Indications: Locally advanced or metastatic bladder cancer in combination with cisplatin. Locally advanced or metastatic adenocarcinoma of the pancreas. In combination with cisplatin, first line treatment of patients [...]

Desmotabs Melt

Bookmark and Share

Company: Ferring Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Desmopressin (free base) 240mcg (as desmopressin acetate). Description: White, round, oral lyophilisate marked with three drop shaped figures on one side. Presentation: 30, €78.24. Indications: Diagnosis and treatment of cranial diabetes insipidus including post-hypophysectomy polyuria/polydipsia and treatment of primary nocturnal enuresis in patients [...]

Glucophage Powder

Bookmark and Share

Company: Merck Serono. Legal Category: Prescription. GMS. Sport permitted. Active ingredient: Metformin (HCl) 500mg. Description: White, odourless powder for oral solution. Presentation: 500mg-30 sachets, €2.23. Indications: Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control (alone or with other oral antidiabetic [...]

Zomacton

Bookmark and Share

Company: Ferring Ireland Ltd. Legal category: Prescription. High Tech. Sport prohibited. Active ingredient: Somatropin 10mg/ml. Description: Powder and solvent for solution for injection in pre-filled syringe. Presentation: 1, €217.96. Indications: Long-term treatment of growth failure in children due to inadequate secretion of growth hormone (GH), and of growth retardation due to Turner’s Syndrome confirmed by [...]

Nutramigen 1, Nutramigen 2 and Pregestimil – Product name change

Bookmark and Share

Mead Johnson Nutrition wish to announce that from September 2010 their infant formulas Nutramigen 1, Nutramigen 2 and Pregestimil will change to:                                                                                            Nutramigen Lipil 1 Nutramigen Lipil 2 Pregestimil Lipil In addition to the name change, LIPIL, a blend of omega 3 and omega 6 long-chain polyunsaturated fats, has been added to help support [...]

Pepti First and Pepti Follow On – Change of Manufacturer and Product Name

Bookmark and Share

Aptamil wishes to announce that from October 2010 Pepti First and Pepti Follow On will stop being produced by Cow & Gate and will start being produced by Aptamil. Only the brand name and packaging will change, the product will remain exactly the same. Pepti First and Pepti Follow On will change to: Pepti 1 [...]

« Previous Page